Patents by Inventor Chieh-I CHEN

Chieh-I CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11932692
    Abstract: The present disclosure provides methods of treating or inhibiting cancer pain in a patient in need thereof, including selecting a patient with cancer, and administering to the patient a therapeutically effective amount of a programmed death 1 (PD-1) inhibitor. The present disclosure also provides methods of reducing analgesic use in a patient in need thereof, including selecting a patient with cancer, and administering to the patient a therapeutically effective amount of a PD-1 inhibitor, wherein the patient is being treated with background analgesic therapy prior to administration of the PD-1 inhibitor. In some embodiments, the disclosed methods concurrently lead to tumor regression, pain reduction, and reduced use of analgesic therapy.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: March 19, 2024
    Assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology
    Inventors: Chieh-I Chen, Medha R. Sasane, Denise P. Bury-Maynard
  • Publication number: 20220242959
    Abstract: The present disclosure relates the dosage modification and choice of an IL6 antibody for the treatment of rheumatoid arthritis in subjects.
    Type: Application
    Filed: June 11, 2020
    Publication date: August 4, 2022
    Inventors: Chieh-I CHEN, Wenhui WEI
  • Publication number: 20220064304
    Abstract: The present disclosure provides methods of treating or inhibiting cancer pain in a patient in need thereof, including selecting a patient with cancer, and administering to the patient a therapeutically effective amount of a programmed death 1 (PD-1) inhibitor. The present disclosure also provides methods of reducing analgesic use in a patient in need thereof, including selecting a patient with cancer, and administering to the patient a therapeutically effective amount of a PD-1 inhibitor, wherein the patient is being treated with background analgesic therapy prior to administration of the PD-1 inhibitor. In some embodiments, the disclosed methods concurrently lead to tumor regression, pain reduction, and reduced use of analgesic therapy.
    Type: Application
    Filed: September 2, 2021
    Publication date: March 3, 2022
    Inventors: Chieh-I Chen, Medha R. Sasane, Denise P. Bury-Maynard
  • Patent number: 10641766
    Abstract: A universal and standalone rapid diagnostics test reader is disclosed herein that includes: a set of control electronics, an illumination component, an imaging component, a housing component, a wireless communication component, a rapid diagnostics test component, a universal rapid diagnostics test tray, wherein the tray can hold at least one rapid diagnostics test component having a shape and a size in a fixed position relative to the imaging component and the illumination component, and wherein the reader can accommodate more than one different rapid diagnostics test component, while using the same universal rapid diagnostics test tray.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: May 5, 2020
    Assignee: NowDiagnostics, Inc.
    Inventors: Onur Mudanyali, Neven Karlovac, Chieh-I Chen, Sz-Wei Wu, Yusi Ou, Yingjun Wu, Michael Williams
  • Publication number: 20170252434
    Abstract: The present invention provides compositions and methods of for improving the Health-Related Quality of Life of a subject suffering from rheumatoid arthritis, comprising administering to the subject an effective amount of sarilumab.
    Type: Application
    Filed: September 15, 2015
    Publication date: September 7, 2017
    Inventors: George Johny JOSEPH, Hubert VAN HOOGSTRATEN, Chieh-I CHEN, Chungpeng FAN, Neil GRAHAM, Tanya Marie MOMTAHEN, Mark GENOVESE